·µ»ØÊ×Ò³
µ±Ç°Î»ÖÃ: > ҽѧÂÛÎÄ > Ò½ ѧ >

ApoE»ùÒò¶à̬ÐÔ¡¢hs-CRPÓë¹ÚÐIJ¡µÄÏà¹ØÐÔÑо¿

ʱ¼ä:2010-01-10 22:31À´Ô´:¹ãÎ÷½ÌÓýÌü¿ÎÌ⣨¹ð½Ì¿ÆÑУÛ2006 ×÷Õß:»ÆÔ¾±ó ºÎÓ¡ÀÙ µã»÷:´Î
¡¾¹Ø¼ü´Ê¡¿ ÔØÖ¬µ°°×E£»»ùÒò¶à̬ÐÔ£»¸ßÃôC?·´Ó¦µ°°×£»¹ÚÐIJ¡ ¡¾ÕªÒª¡¿ Ä¿µÄ ·ÖÎöÔØÖ¬µ°°×E£¨ApoE£©µÄ»ùÒò¶à̬ÐÔ¡¢¸ßÃôC?·´Ó¦µ°°×£¨hs?CRP£©º¬Á¿Óë¹ÚÐIJ¡µÄÏà¹ØÐÔ¡£·½·¨ ²ÉÓ÷ÓÂȷ³éÌáºËËá·¨´ÓÄýѪ¿éÖзÖÀë,Ó¦ÓþۺÏøÁ´·´Ó¦£¨PCR£©£¬Hha1ÄÚÇÐøÏû»¯·¨¶Ô94Àý¹ÚÐÄ
¡¡¡¡

9ApoE»ùÒò¶à̬ÐÔ¡¢hs?CRPÓë¹ÚÐIJ¡µÄÏà¹ØÐÔÑо¿)The correlation of the polymorphism of apolipoprotein E and high sensitivity C?reactive¡¡protein  for coronary heart disease

¡¡¡¡HUANG Yue?Bin£¬HE Yin?Lei.

¡¡¡¡Institute of Laboratory Medicine, Youjiang Nationalities Medical College, Baise 533000, Guangxi, China

¡¡¡¡¡¾Abstract¡¿  Objective  To analyze the polymorphism of apolipoprotein E (ApoE), and high sensitivity C?reactive¡¡protein (hs?CRP) levels and the relevance of coronary heart disease (CHD). Methods  Phenol chloroform extraction was used to get the DNA from the isolated blocks blood coagulation. Polymerase chain reaction, Hhal endonuclease digestion were used to test  the 94 cases of CHD patients and 100 healthy control group ApoE polymorphism. Hs?CRP level was measured by immune latex transmission turbidity. Results  ¢Ù ApoE allele frequency: compared with the control group, ε2 allele frequency decreased significantly (P=0.01) in CHD group, ε4 allele frequency increased (P=0.005). ¢Ú Serum hs?CRP concentration in CHD group was significantly higher than that of control grooup (P£¼0.05), but there was no significant difference between different alleles on hs?CRP. Conclusions  The ApoE gene polymorphism and serum hs?CRP are the sensitive and valuable indicators, which can predict the the risk of cardiovascular disease.
   
¡¡¡¡¡¾Key words¡¿  Apolipoprotein E; Genetic polymorphism; High sensitivity C?reactive¡¡protein; Coronary heart disease

¡¡¡¡9ApoE»ùÒò¶à̬ÐÔ¡¢hs?CRPÓë¹ÚÐIJ¡µÄÏà¹ØÐÔÑо¿)¹ÚÐIJ¡(CHD)Êdz£¼ûµÄ¶à·¢²¡,ÊÇÐÄѪ¹Üϵͳ¼²²¡³£¼ûµÄËÀÍöÔ­ÒòÖ®Ò»¡£Ñо¿ÈÏΪ£¬ÔØÖ¬µ°°×E£¨ApoE£©»ùÒò¶à̬ÐÔÓëCHDÓÐÒ»¶¨µÄÏà¹ØÐÔ¡²1¡«3¡³£¬¹Ú×´¶¯ÂöÖàÑùÓ²»¯²¢²»ÊÇÒ»ÖÖ¼òµ¥µÄÖ¬ÖʳÁ»ý¼²²¡,Ñ×Ö¢ÊÇÆäÖØÒªÌØÕ÷,Òò´Ë,CHDÊÇÒ»ÖÖÑ×ÐÔ¼²²¡¡£¸ßÃôC·´Ó¦µ°°×(hs?CRP)ÓëCHDµÄ¹ØÏµÖð½¥±»ÁÙ´²¹ã·º¹Ø×¢¡£±¾ÎĶÔ94ÀýCHD»¼ÕßѪҺ½øÐÐAopE»ùÒò¶à̬ÐÔ¼°hs?CRPŨ¶È¼ì²â£¬Ö¼ÔÚÑо¿ÑªÇåhs?CRP¡¢ApoE»ùÒò¶à̬ÐÔÓëCHDµÄÏà¹ØÐÔ¡£

¡¡¡¡1  ¶ÔÏóÓë·½·¨

¡¡¡¡1.1  Ñо¿¶ÔÏó  CHD×é94Àý£¬ÆäÖÐ׳×å42Àý£¬ºº×å52Àý£¬¾ùΪÓÒ½­Ãñ×åҽѧԺ¸½ÊôÒ½ÔºÐÄÄÚ¿Æ2007Äê1ÔÂÖÁ2007Äê8ÔÂסԺCHD»¼Õߣ»ÄÐ59Àý£¬Å®35Àý£¬ÄêÁä44¡«77Ë꣬ƽ¾ù£¨60±12.7£©Ë꣬ȫ²¿·ûºÏ1979ÄêÊÀ½çÎÀÉú×éÖ¯ÐÞ¶©µÄCHDÕï¶Ï±ê×¼¡£¶ÔÕÕ×é100Àý£¬¾ùΪͬÆÚסԺµÄ·ÇCHD»¼Õߣ¬²¢ÅųýÐÄÄÔѪ¹Ü¼²²¡¼°¸Î¡¢Éö¡¢ÄÚ·ÖÃÚµÈÓ°ÏìÖ¬ÖÊ´úлµÄ¼²²¡£»ÄÐ56Àý£¬Å®44Àý£¬ÄêÁä45¡«80Ë꣬ƽ¾ù£¨65±10.8£©Ëê¡£ËùÓÐÊÜÊÔÕßÔÚʵÑéǰ¾ùÖªÇéͬÒâ×ÔÔ¸²Î¼Ó±¾ÊµÑé¡£

¡¡¡¡1.2  ·½·¨9ApoE»ùÒò¶à̬ÐÔ¡¢hs?CRPÓë¹ÚÐIJ¡µÄÏà¹ØÐÔÑо¿)

¡¡¡¡1.2.1  ApoE»ùÒò¶à̬ÐԵļì²â

¡¡¡¡1.2.1.1  DNAÌáÈ¡  ²É¿Õ¸¹¾²ÂöѪ2.5¡«3.0 ml£¬EDTA¿¹Äý£¬ÓõÍÉøÈÜѪ·Ó?Âȷ³éÌá°×ϸ°ûºËËáDNA£¬Ë«ÕôË®Èܽâºó×÷Ϊģ°å¡£

¡¡¡¡1.2.1.2  ¾ÛºÏøÁ´·´Ó¦£¨PCR£©À©Ôö  ÒýÎïÉè¼Æ²Î¿¼ÎÄÏס²4¡³£ºÒýÎïÐòÁУ¬ÉÏÓÎÒýÎïP1Ϊ£º 5′?AAC AAC TGA CCC CGG TGG CG?3′,ÏÂÓÎÒýÎïP2Ϊ£º5′?ATG GCG CTG AGG CCG CGC TC?3′,ÓÉÉîÛÚÆ¥»ù¹«Ë¾ºÏ³É¡£PCR·´Ó¦Ìåϵ°üÀ¨10×dNTP(¸÷10 mmol/L)1.0 μl,ÒýÎïP1ºÍP2¸÷0.8 μl£¬¶þ¼×»ùÑÇí¿5 μl£¬DNAÄ£°å1.0 μl£¬Tag DNA¾ÛºÏø2 U£¬¼ÓË«ÕôË®ÖÁ40 μl£¬»ìÔȼ´¿É¡£PCR·´Ó¦Ìõ¼þ£º95¡æÔ¤±äÐÔ2 min£¬È»ºó95¡æ 60 s£¬56¡æ 30 s£¬72¡æ 30 s,¹²35¸öÑ­»·¡£ÓÃ20 g/LÇíÖ¬ÌÇÄý½ºµçӾȷ¶¨ÌØÒìÐÔÀ©Ôö²úÎï(292 bpƬ¶Î)¡£PCR²úÎïµÄøÇз´Ó¦:øÇз´Ó¦Ìåϵ°üÀ¨À©Ôö²úÎï10 U,10×Buffer 5 μl,ÏÞÖÆÐÔÄÚÇÐøHha1 10 U,¼ÓË«ÕôË®ÖÁ×ÜÌå»ý40 μl,ÖÃÓÚ37¡æÎÂÓý3 h¡£

¡¡¡¡1.2.1.3  ApoE»ùÒò·ÖÐÍ  øÇвúÎï¾­100 g/L¾Û±ûõ£°·Äý½ºµçÓ¾,EBȾɫºó×ÏÍâÏßµÆÏ¹۲ì,ÒÔpBR322DNA/HaeΪ·Ö×Ó±êÖ¾Îï,Åжϱê×¼²ÎÕÕÎÄÏס²5¡³·½·¨¡£

¡¡¡¡1.2.2  hs?CRP¼ì²â  ²É¿Õ¸¹¾²ÂöѪ1.0 ml£¬·ÖÀëѪÇ壬²ÉÓÃÈÕÁ¢7060Éú»¯È«×Ô¶¯ÒÇ£¬ÒÔÈ齺ÔöÇ¿ÃâÒß͸Éä±È×Ç·¨¼ì²â¡£

¡¡¡¡1.3  ͳ¼ÆÑ§·ÖÎö  Ñ¡ÓÃSPSS10.0Èí¼þ½øÐÐt¼ìÑé¡£

¡¡¡¡2  ½á¹û9ApoE»ùÒò¶à̬ÐÔ¡¢hs?CRPÓë¹ÚÐIJ¡µÄÏà¹ØÐÔÑо¿)

¡¡¡¡2.1  ApoEµÄ»ùÒòÐͺ͵Èλ»ùÒòƵÂʱȽϼ°Æä¶àëÄÐÔÓëѪÇåhs?CRPº¬Á¿¹ØÏµ  ¼û±í1£¬±í2¡£Óë¶ÔÕÕ×é±È½Ï£¬CHD×éºÍε2µÈλ»ùÒòƵÂÊÃ÷ÏÔ½µµÍ(P£¼0.01)£¬ε4µÈλ»ùÒòƵÂÊÃ÷ÏÔÉý¸ß(P£¼0.05)¡£CHD×éhs?CRPÃ÷ÏÔ¸ßÓÚ¶ÔÕÕ×飬¶ø¸÷µÈλ»ùÒò×é¼äÎÞÏÔÖø²îÒì¡£(ÔðÈα༭£ºÄÏÔÁÂÛÎÄÖÐÐÄ)

¶¥Ò»ÏÂ
(0)
0%
²ÈÒ»ÏÂ
(0)
0%
------·Ö¸ôÏß----------------------------
·¢±íÆÀÂÛ
Çë×Ô¾õ×ñÊØ»¥ÁªÍøÏà¹ØµÄÕþ²ß·¨¹æ£¬ÑϽû·¢²¼É«Çé¡¢±©Á¦¡¢·´¶¯µÄÑÔÂÛ¡£
ÆÀ¼Û:
񡀂:
ÑéÖ¤Âë:µã»÷ÎÒ¸ü»»Í¼Æ¬
ÍÆ¼öÄÚÈÝ